Article
Obesity medication lorcaserin requires brainstem GLP-1 neurons to reduce food intake in mice
2022-05-06
Abstract excerpt
Overweight and obesity are rapidly becoming the “new normal” in developed countries, which promotes a widespread negative impact on human health. Amongst recently developed obesity medications are the serotonin 2C receptor (5-HT 2C R) agonist lorcaserin and glucagon-like peptide-1 receptor (GLP-1R) agonists, but the brain circuits employed by these medications to produce their therapeutic effects remain to be ful...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f45e0bf3-f7a0-5bc9-b82f-2c94f22cb4db
- DOI
- 10.1101/2022.05.06.490598
